EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, HBM Holdings's enterprise value is $61.07 Mil.
HBM Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $89.50 Mil. Therefore, HBM Holdings's EV-to-Revenue for today is 0.68.
The historical rank and industry rank for HBM Holdings's EV-to-Revenue or its related term are showing as below:
HBMHF'
s EV-to-Revenue Range Over the Past 10 Years
Min: -25.7 Med: 1.35 Max: 188.38
Current: 0.66
During the past 6 years, the highest EV-to-Revenue of HBM Holdings was 188.38. The lowest was -25.70. And the median was 1.35.
HBMHF's EV-to-Revenue is ranked better than 89.88% of 1038
companies
in the Biotechnology industry
Industry Median: 7.97
vs HBMHF: 0.66
As of today (2024-05-15), HBM Holdings's stock price is $0.482.
HBM Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.12. Therefore, HBM Holdings's PS Ratio for today is 4.05.
HBM Holdings EV-to-Revenue Historical Data
The historical data trend for HBM Holdings's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of HBM Holdings's EV-to-Revenue
For the Biotechnology subindustry, HBM Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HBM Holdings's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, HBM Holdings's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where HBM Holdings's EV-to-Revenue falls into.
HBM Holdings's current Enterprise Value is $61.07 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. HBM Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $89.50 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HBM Holdings's share price for today is $0.482.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was $0.12.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HBM Holdings EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of HBM Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
HBM Holdings Ltd is a clinical-stage biopharmaceutical company engaged in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. Its products under development are Batoclimab, for the treatment of a wide spectrum of autoimmune diseases; Tanfanercept, for the treatment of moderate-to-severe dry eye disease (DED); HBM4003; HBM9378, to prevent and treat COVID-19, the pandemic respiratory disease caused by the SARS-CoV-2 virus; HBM7008; and others. Its geographical segments are Mainland China, United States, Europe, and others. Majority of revenue is generated from Europe.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HBMHF has been successfully added to your 